In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 70 for your search:
Cancer Type/Condition:  Extrahepatic bile duct cancer
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000454401, GERCOR-TAUROX, SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RaMM-BO 2.0, NCT01041612
3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 19 to 70
Sponsor: Other
Protocol IDs: SNUBH-GS-HBP2, B-0712-052-006 (local IRB), NCT01111591
4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H10-02829, NCT01514214
5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDM00047339, E7059, NCT01774019
6.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000470411, FFCD-9902, SANOFI-FFCD-9902, LILLY-FFCD-9902, FFCD-FNCLCC-SFRO-9902, NCT00304135
7.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 12 to 70
Sponsor: Other
Protocol IDs: ICMR- D.O No.5/8/7/26/99-ECD-1, NCT01438450
8.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRE 2012.153, NCT01721174
9.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: RFA2012, NCT01739465
10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRUK-HE3002, EU-20629, EUDRACT-2005-003318-13, ISRCTN72785446, CRUK-BILCAP, CRUK-BIBF1120, NCT00363584
11.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 2009-0056, NCT00869635
12.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000696193, FRE-FNCLCC-ACCORD-18/0803, FRE-FNCLCC-PRODIGE-12, EUDRACT-2008-004560-39, EU-20982, FNCLCC-ACCORD-18/0803, NCT01313377
13.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-05-070, NCT01470443
14.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KH0LEE, NCT01622803
15.

Phase: Phase III
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CHU-0137, 2011-A00911-40, NCT01775449
16.

Phase: Phase III
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-X387, NCT01790035
17.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 14865, NCT01303159
18.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BBI608-201, NCT01325441
19.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-131, NCT01545141
20.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 70
Sponsor: Other
Protocol IDs: 271296-HMO-CTIL, NCT00149006
21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 85
Sponsor: Other
Protocol IDs: S-12005, NCT00197431
22.

Phase: Phase II
Type: Treatment
Status: Active
Age: No age specified
Sponsor: Other
Protocol IDs: HSC-MS-04-259, NCT00178698
23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: WUCC-0701, NCT00454519
24.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: GRID, NCT00765570
25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: EudraCT 2008-002367-14, S-20080081, 2612-3769, NCT00779454
1    
New Search